Table of Contents
1. Executive Summary
2. Market Overview
3. Animal Health M&A Deal Volume 2023-2026
4. Major Transactions
5. Veterinary Practice Consolidation Deals
6. Pet Insurance and Telemedicine M&A
7. Pet Food M&A
8. Diagnostics M&A
9. Specialty Biotech Acquisitions
10. Cross-Border M&A
11. Valuation Multiples
12. Integration Outcomes
13. Strategic Rationale Analysis
14. M&A Outlook 2026-2028
15. Appendix

List of Tables
Table 1. Animal Health M&A Deal Volume and Value 2023-2026
Table 2. Top 20 Transactions by Deal Value
Table 3. Veterinary Practice Consolidation Deal Activity
Table 4. Pet Insurance and Telemedicine Transactions
Table 5. Pet Food and Therapeutic Diet M&A
Table 6. Diagnostics and Genomics Acquisitions
Table 7. Specialty Biotech Deal Activity
Table 8. Cross-Border Transaction Map
Table 9. Valuation Multiple Trends by Segment
Table 10. Integration Outcome Tracking by Deal
 

List of Figures
Figure 1. Animal Health M&A Deal Volume 2023-2026
Figure 2. Deal Value Distribution by Segment
Figure 3. Major Transaction Timeline
Figure 4. Veterinary Practice Roll-Up Activity
Figure 5. Diagnostics M&A Trend
Figure 6. Cross-Border Deal Map
Figure 7. Valuation Multiple Trends
Figure 8. Integration Success Scorecard
 

Companies Profiled
Antech Diagnostics
Basepaws
Boehringer Ingelheim Animal Health
Dechra Pharmaceuticals
Elanco Animal Health
EQT
Heska
IDEXX Laboratories
Mars Petcare
Merck Animal Health
Phibro Animal Health
Zoetis